Disclaimer: This BPC-157 calculator is for educational and informational purposes only
GLP-1 slows the stomach and dampens appetite
Stay connected with friends, family, or support groups
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
If brand-name GLP-1 medications are not covered by your insurance or are prohibitively expensive, compounding pharmacies like Empower and Empower tirzepatide formulations offer alternatives at significantly lower price points
Other factors may also contribute to this, such as other medications or health conditions impacting our ability to lose weight